MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C - Concepedia

Concepedia

Publication | Open Access

MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

DOI Full Paper Access

91

Citations

31

References

2006

Year

Narayan Dharel, Naoya Kato, Ryosuke Muroyama, Masaru Moriyama, Run–Xuan Shao, Takao Kawabe, Masao Omata

Clinical Cancer Research

Abstract

The MDM2 promoter SNP309 is associated with the presence of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.

References

	Year	Citations

Page 1